Koski Robert C's Form 4 filing
Oragenics Inc (OGEN) · filed Dec 1, 2022
- Accession no.
- 0001493152-22-034167
- Filed
- Dec 1, 2022, 4:08 PM ET
- Trade date
- Nov 29-30, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $76.7K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Koski Robert CCIK 0001234880 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 29, 2022 | Common Stock | SSaleDisposed | −200,000 | $0.1923 | −$38,460 | 1,576,483 | Indirect | |
| Nov 30, 2022 | Common Stock | SSaleDisposed | −200,000 | $0.1911 | −$38,220 | 1,376,483 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.